Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

The effect of neoadjuvant radiotherapy on immune cell infiltrates in myxofibrosarcoma.

Immuno-oncology technology·2026
Same author

ESMO-ESTRO consensus statements on the safety of combining radiotherapy with EGFR, ALK, or BRAF/MEK inhibitors.

ESMO open·2026
Same author

Liver Metastases Treated With Magnetic Resonance Imaging Guided Stereotactic Body Radiation Therapy: Outcomes of Tolerability, Acute Toxicity, and Quality of Life From the MOMENTUM Study.

Practical radiation oncology·2025
Same author

The potential of targeted radionuclide therapy to treat hypoxic tumor cells.

Nuclear medicine and biology·2024
Same author

MitoTam induces ferroptosis and increases radiosensitivity in head and neck cancer cells.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2024
Same author

Longitudinal Image Data for Outcome Modeling.

Clinical oncology (Royal College of Radiologists (Great Britain))·2024

相关实验视频

Updated: Jul 5, 2025

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
10:48

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator

Published on: December 28, 2017

9.5K

放射治疗反应的可图像生物标志物

W Woliner-van der Weg, P N Span, P M Braam

    Progress in tumor research
    |January 20, 2024
    PubMed
    概括

    识别瘤缺氧和扩散的可图像生物标志物可以个性化放射治疗,优化治疗疗效,同时最大限度地减少癌症患者的毒性. 这种方法旨在提前定制治疗强度和策略.

    科学领域:

    • 在瘤学瘤学.
    • 辐射疗法 辐射疗法
    • 医疗成像医学成像

    背景情况:

    • 优化放射治疗需要平衡瘤杀伤效应与毒性.
    • 由于瘤缺氧和扩散等因素导致的放射治疗耐药性,需要个性化治疗策略.
    • 目前克服耐药性的方法可能会导致一些患者出现不可接受的副作用.

    研究的目的:

    • 探索可图像化生物标志物的潜力,以量身定制放射治疗.
    • 讨论可以识别瘤缺氧和扩散的生物标志物.
    • 为了使患者能够提前选择最佳的放射治疗方法.

    主要方法:

    • 对缺氧和扩散的可图像生物标志物的审查.
    • 讨论生物标记机制和成像程序.
    • 对量化方法和临床价值的分析.

    主要成果:

    • 可图像化的生物标志物为个性化放射治疗提供了一条途径.
    • 特定的生物标志物可以评估瘤缺氧和扩散.
    • 这些生物标志物有助于选择适当的治疗强化或组合策略.

    结论:

    更多相关视频

    Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
    04:09

    Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

    Published on: October 10, 2018

    8.3K
    Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine
    05:39

    Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine

    Published on: April 5, 2024

    844

    相关实验视频

    Last Updated: Jul 5, 2025

    PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
    10:48

    PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator

    Published on: December 28, 2017

    9.5K
    Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
    04:09

    Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

    Published on: October 10, 2018

    8.3K
    Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine
    05:39

    Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine

    Published on: April 5, 2024

    844
    • 可图像化的生物标志物对于量身定制的放射治疗至关重要.
    • 预先评估缺氧和扩散可以指导治疗决策.
    • 这种个性化的方法旨在改善结果并减少副作用.